Drozapol-Profil Balance Sheet Health
Financial Health criteria checks 5/6
Drozapol-Profil has a total shareholder equity of PLN66.3M and total debt of PLN708.0K, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are PLN84.2M and PLN17.9M respectively.
Key information
1.1%
Debt to equity ratio
zł708.00k
Debt
| Interest coverage ratio | n/a |
| Cash | zł5.96m |
| Equity | zł66.34m |
| Total liabilities | zł17.90m |
| Total assets | zł84.24m |
Recent financial health updates
Recent updates
Drozapol-Profil's (WSE:DPL) Returns On Capital Are Heading Higher
Jan 19
Returns At Drozapol-Profil (WSE:DPL) Are On The Way Up
Apr 28Shareholders Would Enjoy A Repeat Of Drozapol-Profil's (WSE:DPL) Recent Growth In Returns
Oct 18Here's Why We Think Drozapol-Profil (WSE:DPL) Is Well Worth Watching
Jun 03Do Drozapol-Profil's (WSE:DPL) Earnings Warrant Your Attention?
Mar 03Investors Will Want Drozapol-Profil's (WSE:DPL) Growth In ROCE To Persist
Aug 02Drozapol-Profil's (WSE:DPL) Solid Earnings May Rest On Weak Foundations
Jun 06Here's Why Drozapol-Profil (WSE:DPL) Can Manage Its Debt Responsibly
May 17Financial Position Analysis
Short Term Liabilities: DPL's short term assets (PLN42.9M) exceed its short term liabilities (PLN11.9M).
Long Term Liabilities: DPL's short term assets (PLN42.9M) exceed its long term liabilities (PLN6.1M).
Debt to Equity History and Analysis
Debt Level: DPL has more cash than its total debt.
Reducing Debt: DPL's debt to equity ratio has reduced from 14.7% to 1.1% over the past 5 years.
Debt Coverage: DPL's debt is well covered by operating cash flow (1176%).
Interest Coverage: Insufficient data to determine if DPL's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 04:57 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Drozapol-Profil S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|